GSK plc
GSK
#225
Rank
A$149.22 B
Marketcap
A$74.44
Share price
2.40%
Change (1 day)
2.21%
Change (1 year)

GSK plc (GSK) - P/B ratio

P/B ratio as of November 2026 : 4.24

According to GSK plc's latest financial reports the company has a price-to-book ratio of 2.31431.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

GSK plc - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-314.68-20.37%
2022-12-315.8855.22%
2021-12-313.7917.06%
2020-12-313.24-33.08%
2019-12-314.83-76.01%
2018-12-3120.27.85%
2017-12-3118.721.55%
2016-12-3115.4104.19%
2015-12-317.53-44.45%
2014-12-3113.635.39%
2013-12-3110.03.07%
2012-12-319.7115.46%
2011-12-318.4124.2%
2010-12-316.777.37%
2009-12-316.31-20.44%
2008-12-317.9312.58%
2007-12-317.04-12.13%
2006-12-318.02-29.23%
2005-12-3111.3-4.99%
2004-12-3111.936.9%
2003-12-318.71-27.8%
2002-12-3112.1

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Novartis
NVS
8.23 94.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.95-54.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.45-65.76%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
8.73 105.93%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5.83 37.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
6.46 52.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
3.41-19.67%๐Ÿ‡บ๐Ÿ‡ธ USA